Literature DB >> 3711202

Highly sensitive determination of N-acetyl- and N-glycolylneuraminic acids in human serum and urine and rat serum by reversed-phase liquid chromatography with fluorescence detection.

S Hara, M Yamaguchi, Y Takemori, M Nakamura, Y Ohkura.   

Abstract

A simple, rapid and highly sensitive high-performance liquid chromatographic method for the determination of N-acetyl- and N-glycolylneuraminic acids in serum and urine is described. The neuraminic acids, released by hydrolysis of serum and urine, are converted in dilute sulphuric acid with 1,2-diamino-4,5-dimethoxybenzene, a fluorogenic reagent for alpha-keto acids, to highly fluorescent derivatives. The derivatives are separated isocratically within 8 min by reversed-phase chromatography using a Radial-Pak cartridge C18 column and detected fluorimetrically. The limit of detection is 40 fmol (12 pg) for both neuraminic acids in 10-microliters injection volume [0.3 nmol (90 ng)/ml) of serum or urine]. This sensitivity permits the precise determination of the neuraminic acids in 5 microliters of serum or urine. The method was applied to the determination of the neuraminic acids in sera from normal subjects and cancer patients, normal urine and rat serum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711202     DOI: 10.1016/s0378-4347(00)80766-5

Source DB:  PubMed          Journal:  J Chromatogr


  15 in total

1.  Quantifying the Efficiency of N-Phenyl-D-mannosamine to Metabolically Engineer Sialic Acid on Cancer Cell Surface.

Authors:  Zhifang Zhou; Guochao Liao; Sergejs Stepanovs; Zhongwu Guo
Journal:  J Carbohydr Chem       Date:  2014-11-01       Impact factor: 1.667

2.  Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins.

Authors:  Youichi Tajima; Eiichiro Uyama; Shinji Go; Chihiro Sato; Nodoka Tao; Masaharu Kotani; Hirotake Hino; Akemi Suzuki; Yutaka Sanai; Ken Kitajima; Hitoshi Sakuraba
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Evidence for mitochondrial localization of a novel human sialidase (NEU4).

Authors:  Kazunori Yamaguchi; Keiko Hata; Koichi Koseki; Kazuhiro Shiozaki; Hirotoshi Akita; Tadashi Wada; Setsuko Moriya; Taeko Miyagi
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Sialidases as regulators of bioengineered cellular surfaces.

Authors:  Cristina Y Zamora; Matthew J Ryan; Marc d'Alarcao; Krishna Kumar
Journal:  Glycobiology       Date:  2015-03-20       Impact factor: 4.313

Review 5.  Recent advances in sialic acid-focused glycomics.

Authors:  Huan Nie; Yu Li; Xue-Long Sun
Journal:  J Proteomics       Date:  2012-04-05       Impact factor: 4.044

6.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

7.  Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.

Authors:  Vered Padler-Karavani; Hai Yu; Hongzhi Cao; Harshal Chokhawala; Felix Karp; Nissi Varki; Xi Chen; Ajit Varki
Journal:  Glycobiology       Date:  2008-07-31       Impact factor: 4.313

8.  Sialic acid speciation using capillary electrophoresis: optimization of analyte derivatization and separation.

Authors:  Zoltan Szabo; Jonathan Bones; Andras Guttman; James Glick; Barry L Karger
Journal:  Anal Chem       Date:  2012-08-29       Impact factor: 6.986

9.  Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.

Authors:  Sandra L Diaz; Vered Padler-Karavani; Darius Ghaderi; Nancy Hurtado-Ziola; Hai Yu; Xi Chen; Els C M Brinkman-Van der Linden; Ajit Varki; Nissi M Varki
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

10.  Sialic acid utilisation and synthesis in the neonatal rat revisited.

Authors:  Peter I Duncan; Frédéric Raymond; Andreas Fuerholz; Norbert Sprenger
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.